mhurhangee/patent-ind-claim-en huggingface dataset:
Pneumatic vehicle tyre with a belt consisting of at least one steel cord belt ply , which encircles the tyre circumference, and a bandage which externally bears radially on the belt over the entire tyre circumference, wherein the bandage consists of a rubber strip in which two to six cords of reinforcement fibres are contained, and this rubber strip in a winding direction relative to the circumferential direction of the pneumatic vehicle tyre is wound about the belt at least from one axial end of the belt up to at least the other axial end of the belt , wherein the ratio of the component of the winding direction in the axial direction (A) to the component of the winding direction in the circumferential direction along the rubber strip is less than 0.01, and does not vary by more than 2% over at least 70% of the width (W G ) of the belt in the axial direction (A), characterized in that the spacing of two neighbouring cords in two adjacent portions of the rubber strip at each circumferential position does not vary by more than 5% in comparison to the spacing of the cords in the rubber strip , and the cords in the bandage are subjected to a tension of at least 3 N/mm 2 over at least 25% of the width (W G ) of the belt in the axial direction (A).
Pressure washing apparatus with a pressure generation unit for pressurizing a fluid, characterized by a control apparatus which is configured to detect a used hose attachment or a used fluid jet type on the basis of a pressure variation curve and/or an operating pressure variation curve detected by a pressure sensor ; and/or on the basis of a current throughflow quantity or a throughflow quantity variation curve detected via a throughflow quantity sensor.
A semiconductor memory device comprising: a conductive pattern, (CP), extending in a first direction, (D1); a magnetic tunnel junction pattern, (MTJ), on the conductive pattern; and a capacitor, (CAP), CAP, on the magnetic tunnel junction pattern, wherein the magnetic tunnel junction pattern is between the conductive pattern and the capacitor, and the magnetic tunnel junction pattern connects to the capacitor, and the conductive pattern is configured to apply spin-orbit torque to the magnetic tunnel junction pattern. a conductive pattern, (CP), extending in a first direction, (D1); a magnetic tunnel junction pattern, (MTJ), on the conductive pattern; and a capacitor, (CAP), CAP, on the magnetic tunnel junction pattern, wherein the magnetic tunnel junction pattern is between the conductive pattern and the capacitor, and the magnetic tunnel junction pattern connects to the capacitor, and the conductive pattern is configured to apply spin-orbit torque to the magnetic tunnel junction pattern.
A cloned or recombinant defective interfering influenza A virus for use in a method of treatment or prophylaxis of respiratory virus infections, wherein the cloned or recombinant defective interfering influenza A virus comprises RNA derived from segment 1, 2 or 3, wherein said RNA comprises: (a) an RNA of between 300 to 600 nucleotides in length; (b) at least 100 nucleotides from the 5' and 3' ends of segment 1, 2 or 3; and (c) a central deletion of nucleotides of said segment; wherein said defective interfering influenza virus is capable of interfering with RNA production from segments 1, 2 and 3 of influenza A, and wherein said defective interfering influenza virus is not 1/244. wherein the cloned or recombinant defective interfering influenza A virus comprises RNA derived from segment 1, 2 or 3, wherein said RNA comprises: (a) an RNA of between 300 to 600 nucleotides in length; (b) at least 100 nucleotides from the 5' and 3' ends of segment 1, 2 or 3; and (c) a central deletion of nucleotides of said segment; (a) an RNA of between 300 to 600 nucleotides in length; (b) at least 100 nucleotides from the 5' and 3' ends of segment 1, 2 or 3; and (c) a central deletion of nucleotides of said segment; wherein said defective interfering influenza virus is capable of interfering with RNA production from segments 1, 2 and 3 of influenza A, and wherein said defective interfering influenza virus is not 1/244.
A use of cork material in the preparation of dough, especially bread dough, wherein the cork material consists of natural cork granules with a grain size of 0.5 to 5 mm in an amount of 80 to 90% by volume, bounded by a binder in an amount of 10 to 20% by volume with a strength of 700 to 800 kPa and a density of 200 to 370 kg/m3, wherein the cork material is used for dough proofing molds.
A thermoelectric device for heating or cooling, comprising an elongated panel , formed of an electrically insulating material, and a plurality of thermoelectric elements comprising n-type and p-type thermoelectric elements, wherein the n-type and p-type thermoelectric elements are alternatingly interconnected with one another in series by conductors, wherein the thermoelectric elements run substantially parallel to or at an acute angle relative to a long dimension of the panel , characterized in that the conductors are compacted in transverse dimension when located inside of the insulating material and are expanded in transverse dimension when located outside of the insulating material, wherein the conductors are arranged to extend from the opposite outside surfaces of the panel , so as to effect to heating or cooling of the respective outside surfaces.
A door-locking module for a door of a household appliance, comprising: a housing ; a printed circuit board (4, PCB), received within said housing and comprising at least one first actuator switch adapted to open and close a predetermined first circuit of said PCB ; a locking pin configured to move between a locked position, affecting the door into a locked state, and an unlocked position, affecting the door into an unlocked state; an actuator , operably coupled to said locking pin so as to controllably move said locking pin between said unlocked position and said locked position, and a locking ring , operably coupled between said actuator and said at least one first actuator switch , comprising at least one cam guide adapted to cooperate with a corresponding cam follower of said locking pin , characterised in that , said locking ring further comprising a trigger member adapted to operably engage with said first actuator switch . a printed circuit board (4, PCB), received within said housing and comprising at least one first actuator switch adapted to open and close a predetermined first circuit of said PCB ; a locking pin configured to move between a locked position, affecting the door into a locked state, and an unlocked position, affecting the door into an unlocked state; an actuator , operably coupled to said locking pin so as to controllably move said locking pin between said unlocked position and said locked position, and a locking ring , operably coupled between said actuator and said at least one first actuator switch , comprising at least one cam guide adapted to cooperate with a corresponding cam follower of said locking pin , characterised in that , said locking ring further comprising a trigger member adapted to operably engage with said first actuator switch .
A bracket for at least one object holder and a cover plate for receiving objects for the examination by means of microscopy, comprising at least two rails for receiving respectively at least one object holder and respectively at least one cover plate , wherein each of the two rails has at least two recesses which are arranged one above the other and each have an U-shaped cross section, into which recesses respectively the object holder and above it the cover plate are being inserted, and the recesses extend laterally along the longitudinal side of the respective rail , wherein respectively one recess of the two rails has a height H1 which corresponds to the thickness of the respective object holder to be received and respectively one recess of the two rails has a height H2 which corresponds to the thickness of the respective cover plate to be received, wherein the two recesses of the rails have a distance A relative to each other, which corresponds to at least the height of the object to be received.
A method for quantifying a therapeutic antibody in a sample of a human individual comprising the steps of: a) adding to a test sample which may contain therapeutic antibodies to be quantified a known amount of two or more labeled forms of said therapeutic antibodies, whereby a pre-proteolysis sample is provided, b) subjecting the pre-proteolysis sample to an enzyme proteolysis, so as to provide a proteolysis sample comprising (i) proteolysis labeled peptides derived from the labeled therapeutic antibodies and (ii) proteolysis peptides derived from the therapeutic antibody contained in the test sample, c) determining by mass spectrometric analysis the ratio between (i) one or more selected proteolysis labeled peptides and (ii) one or more corresponding proteolysis peptides derived from the said therapeutic antibody, d) calculating from the ratio determined at step c) the amount of the said therapeutic antibody in the test sample; wherein the test sample is a human plasma sample or a human serum sample, and the two or more antibodies are selected in a group consisting of: Infliximab, Etanercept, Adalimumab, Certolizumab, Golimumab, Trastuzumab, Rituximab and Bevacizumab. a) adding to a test sample which may contain therapeutic antibodies to be quantified a known amount of two or more labeled forms of said therapeutic antibodies, whereby a pre-proteolysis sample is provided, b) subjecting the pre-proteolysis sample to an enzyme proteolysis, so as to provide a proteolysis sample comprising (i) proteolysis labeled peptides derived from the labeled therapeutic antibodies and (ii) proteolysis peptides derived from the therapeutic antibody contained in the test sample, c) determining by mass spectrometric analysis the ratio between (i) one or more selected proteolysis labeled peptides and (ii) one or more corresponding proteolysis peptides derived from the said therapeutic antibody, d) calculating from the ratio determined at step c) the amount of the said therapeutic antibody in the test sample;
A method of making a vacuum insulated glass (VIG) window unit, the method comprising: removing an existing stop from a window sash , said existing stop having supported a previously installed non-vacuum insulated glass window with a larger width; seating a VIG window on said window sash , the window sash capable of supporting a non-vacuum insulating glass window which has a larger width than does the VIG window , said VIG window being supported on a first side by a stop portion of said window sash and having a width less than the width of said non-vacuum insulated glass window; and installing a VIG stop so that the VIG stop is connected to said window sash and supports a second side of said VIG window opposite said first side, wherein said VIG stop has a width sufficient to compensate for a difference in the width of said non-vacuum insulated glass window and said VIG window, wherein said VIG stop comprises a hollow portion defined by a plurality of sidewalls, wherein the hollow interior portion is filled with insulating foam, and wherein the VIG stop has a width of at least 5 mm greater than a width of the existing stop. removing an existing stop from a window sash , said existing stop having supported a previously installed non-vacuum insulated glass window with a larger width; seating a VIG window on said window sash , the window sash capable of supporting a non-vacuum insulating glass window which has a larger width than does the VIG window , said VIG window being supported on a first side by a stop portion of said window sash and having a width less than the width of said non-vacuum insulated glass window; and installing a VIG stop so that the VIG stop is connected to said window sash and supports a second side of said VIG window opposite said first side, wherein said VIG stop has a width sufficient to compensate for a difference in the width of said non-vacuum insulated glass window and said VIG window, wherein said VIG stop comprises a hollow portion defined by a plurality of sidewalls, wherein the hollow interior portion is filled with insulating foam, and wherein the VIG stop has a width of at least 5 mm greater than a width of the existing stop.
Method for producing a glass container , such as a glass syringe or a glass ampule, having a form-specific dispensing portion and optionally a form-specific counter support , from a glass container blank , wherein: - the basis weight of the glass container blank is detected indirectly or directly; and - an individual overall longitudinal extent of a semi-finished glass container to be formed to create the glass container is determined on the basis of the detected basis weight. - the basis weight of the glass container blank is detected indirectly or directly; and - an individual overall longitudinal extent of a semi-finished glass container to be formed to create the glass container is determined on the basis of the detected basis weight.
A copper alloy wire rod comprising: Ag: 0.5 wt% or more and 6 wt% or less and the balance including inevitable impurities and Cu, wherein, on a cross section parallel to a longitudinal direction of the copper alloy wire rod, within a range observed with a visual field of 1.7 μm in a direction perpendicular to the longitudinal direction and 2.3 μm in a direction parallel to the longitudinal direction, the copper alloy wire rod has at least one rectangular range that is a rectangular range having a width perpendicular to the longitudinal direction of 0.2 μm and a length parallel to the longitudinal direction of 2.3 μm and entirely includes five or more second phase particles containing Ag and having a maximum length in the longitudinal direction of less than 300 nm. Ag: 0.5 wt% or more and 6 wt% or less and the balance including inevitable impurities and Cu, wherein, on a cross section parallel to a longitudinal direction of the copper alloy wire rod, within a range observed with a visual field of 1.7 μm in a direction perpendicular to the longitudinal direction and 2.3 μm in a direction parallel to the longitudinal direction, the copper alloy wire rod has at least one rectangular range that is a rectangular range having a width perpendicular to the longitudinal direction of 0.2 μm and a length parallel to the longitudinal direction of 2.3 μm and entirely includes five or more second phase particles containing Ag and having a maximum length in the longitudinal direction of less than 300 nm.
A stapler comprising: a driving portion configured to drive a staple into a sheet bundle (P); a clinch portion configured to bend a leg portion of the staple driven into and penetrating the sheet bundle (P); a table link configured to support the clinch portion at a position facing the driving portion and move the clinch portion in a first direction in which the clinch portion separated from and brought into contact with the driving portion ; a motor configured to drive the driving portion ; and a regulation portion configured to move in a second direction intersecting the first direction while abutting against the table link and regulate a movement of the clinch portion in a direction away from the driving portion , characterized in that the regulation portion is further configured such that a position where the regulation portion abuts against the table link changes in a direction toward the clinch portion as the clinch portion and the driving portion are separated from each other. a driving portion configured to drive a staple into a sheet bundle (P); a clinch portion configured to bend a leg portion of the staple driven into and penetrating the sheet bundle (P); a table link configured to support the clinch portion at a position facing the driving portion and move the clinch portion in a first direction in which the clinch portion separated from and brought into contact with the driving portion ; a motor configured to drive the driving portion ; and a regulation portion configured to move in a second direction intersecting the first direction while abutting against the table link and regulate a movement of the clinch portion in a direction away from the driving portion , characterized in that the regulation portion is further configured such that a position where the regulation portion abuts against the table link changes in a direction toward the clinch portion as the clinch portion and the driving portion are separated from each other.
A device for filtering liquids in a machine tool, the device having a filter bed , a filter medium adapted to be conveyed over the filter bed, an intake chamber for the liquid to be filtered, the intake chamber being delimited by the filter medium , a clean tank for the filtered liquid, and a pump configured to supply the filtered liquid from the clean tank to tools of the machine tool, the filter bed and the intake chamber being divided, in a transport direction of the filter medium , into an upstream wash-up zone and a downstream working zone , a collection system (26, 15; 50) being provided for collecting the filtered liquid that has passed through the filter medium in the wash-up zone , the collection system being separate from the clean tank , and a circulation system (18, 20, 22; 52, 54) being provided for recirculating the filtered liquid from the collection system into the intake chamber , characterized in that a mud-tank is provided for collecting the liquid to be filtered, the mud-tank being provided separately from the collection system and being connected to an inlet port in the wash-up zone , the liquid from the mud-tank being capable of being supplied into the intake chamber via a pump and an intake line , and the collection system has a collection chamber that is connected to an inlet port in the working zone via the circulation system .
A multiphase cleaning tablet comprising - a first cleaner phase with an alkali system with one or more components, of which at least one contact-unsuitable component comprises sodium hydroxide (caustic soda), and - a second cleaner phase to cover the first cleaner phase, wherein the second cleaner phase contains no contact-unsuitable components, namely no caustic, toxic or hydroscopic components, optionally also no irritating components, wherein the cleaning tablet is constructed as a tablet with at least three-layer with a first layer of the second cleaner phase, a second, middle layer of the first cleaner phase and a third layer of the second cleaner phase, wherein at least a part of a region of the contact-unsuitable first contact cleaner phase that is is not covered by a layer of the second cleaner phase, in particular at least a part of the boundary edges of the cleaning tablet, is provided with a water-soluble protective film. - a first cleaner phase with an alkali system with one or more components, of which at least one contact-unsuitable component comprises sodium hydroxide (caustic soda), and - a second cleaner phase to cover the first cleaner phase, wherein the second cleaner phase contains no contact-unsuitable components, namely no caustic, toxic or hydroscopic components, optionally also no irritating components,
A method of producing, from a target element, comprised in a target compound, a target element radioisotope, comprised in a target element radioisotope compound, wherein the method is performed in a a radiation therapy device that is adapted to produce an electron beam and wherein the radiation therapy device comprises a gamma radiation target adapted to be irradiated with said electron beam in order to produce gamma radiation ; characterised in that the method comprises the following steps: - providing a module located in the path of the electron beam upstream of the gamma radiation target of the radiation therapy device, the module containing the target compound and a gamma radiation source element or compound ; and wherein the target compound is in gaseous form and is contained in a target compound chamber defined by said module; - irradiating said gamma radiation source element or compound with the electron beam, thus causing the gamma radiation source element or compound to produce gamma radiation; said gamma radiation in turn irradiating the target compound, thereby producing the target element radioisotope, wherein the target element radioisotope is of different oxidation state than the target element and is comprised in a target element radioisotope compound that is different from the target compound and that is separable from the target compound by a physical and/or chemical separation method. - providing a module located in the path of the electron beam upstream of the gamma radiation target of the radiation therapy device, the module containing the target compound and a gamma radiation source element or compound ; and wherein the target compound is in gaseous form and is contained in a target compound chamber defined by said module; - irradiating said gamma radiation source element or compound with the electron beam, thus causing the gamma radiation source element or compound to produce gamma radiation;
Structure, the structure comprising a first precast concrete element and a second precast concrete element , the precast concrete elements forming walls and/or supports of the structure, the precast concrete elements being joined to one another at a joint formed between the precast concrete elements , the joint being at least partially filled with filling material , wherein at least one joining means bridging the joint is provided, wherein a first section of the joining means is located in a first receptacle filled with filling material in the first precast concrete element and a second section is located in a second receptacle of the second precast concrete element , characterised in that the first precast concrete element and the second precast concrete element are joined by the joining means exclusively by way of the filling material , and in that the base of the at least one receptacle rises from a lowest point towards both opposite outsides of the structure .
A stent-graft , comprising a first graft and a second graft surrounding the first graft , wherein a plurality of filaments and a stent are disposed between the first graft and the second graft in a radial direction, and wherein the plurality of filaments , the first graft and the second graft are all fastened to the stent, characterized in that : the plurality of filaments each spiral axially with respect to the stent-graft , the plurality of filaments spiral in opposite directions at a same angle with respect to the central axis of the stent-graft , and the plurality of filaments are configured to impart both good flexibility and high strength to the stent-graft.